{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:44:27Z","timestamp":1773413067367,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1652,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.bbmt.2010.05.002","type":"journal-article","created":{"date-parts":[[2010,6,21]],"date-time":"2010-06-21T08:21:13Z","timestamp":1277108473000},"page":"1458-1462","source":"Crossref","is-referenced-by-count":42,"title":["Alternate-Day Micafungin Antifungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Pharmacokinetic Study"],"prefix":"10.1016","volume":"16","author":[{"given":"Parinda A.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander A.","family":"Vinks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Filipovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Bleesing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonata","family":"Jodele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Tarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Fearing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella M.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2010.05.002_bib1","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1086\/313445","article-title":"Aspergillosis in children with cancer: a 34-year experience","volume":"29","author":"Abbasi","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2010.05.002_bib2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1055\/s-2008-1043890","article-title":"Lipid formulations of amphotericin B: clinical perspectives for the management of invasive fungal infections in children with cancer","volume":"210","author":"Groll","year":"1998","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.bbmt.2010.05.002_bib3","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/sj.bmt.1702654","article-title":"Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years","volume":"26","author":"Hovi","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.05.002_bib4","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/JCM.40.3.852-856.2002","article-title":"Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000","volume":"40","author":"Pfaller","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bbmt.2010.05.002_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/515129","volume":"28","author":"Menichetti","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2010.05.002_bib6","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/1097-0142(19940415)73:8<2099::AID-CNCR2820730814>3.0.CO;2-N","article-title":"Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B","volume":"73","author":"Bodey","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2010.05.002_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00003495-199244010-00002","article-title":"Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications","volume":"44","author":"Lyman","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.bbmt.2010.05.002_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.7164\/antibiotics.55.219","article-title":"Antifungal mechanism of FK463 against Candida albicans and Aspergillus fumigatus","volume":"55","author":"Hatano","year":"2002","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.bbmt.2010.05.002_bib9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/AAC.44.3.614-618.2000","article-title":"Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis","volume":"44","author":"Ikeda","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbmt.2010.05.002_bib10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1128\/AAC.44.3.619-621.2000","article-title":"Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis","volume":"44","author":"Matsumoto","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbmt.2010.05.002_bib11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/jac\/46.3.485","article-title":"In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide","volume":"46","author":"Mikamo","year":"2000","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.bbmt.2010.05.002_bib12","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1128\/AAC.46.6.1857-1869.2002","article-title":"Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits","volume":"46","author":"Petraitis","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbmt.2010.05.002_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/AAC.44.1.57-62.2000","article-title":"In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi","volume":"44","author":"Tawara","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbmt.2010.05.002_bib14","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/AAC.45.12.3322-3327.2001","article-title":"Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits","volume":"45","author":"Groll","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbmt.2010.05.002_bib15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2036.2004.02083.x","article-title":"Successful treatment of oesophageal candidiasis by micafungin: a novel systemic antifungal agent","volume":"20","author":"Pettengell","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bbmt.2010.05.002_bib16","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/AAC.49.8.3317-3324.2005","article-title":"Safety, tolerability, and pharmacokinetics of micafungin (FK463) in febrile neutropenic pediatric patients","volume":"49","author":"Seibel","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbmt.2010.05.002_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/00148581-200911040-00006","article-title":"Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients","volume":"11","author":"Carter","year":"2009","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.bbmt.2010.05.002_bib18","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/INF.0b013e3181a0cfd1","article-title":"Pharmacokinetics of prophylactic micafungin in very-low-birth-weight infants","volume":"28","author":"Kawada","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bbmt.2010.05.002_bib19","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1177\/0091270005279580","article-title":"Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunction","volume":"45","author":"Hebert","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.bbmt.2010.05.002_bib20","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1177\/0091270005279274","article-title":"Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers","volume":"45","author":"Hebert","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.bbmt.2010.05.002_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01657-09","article-title":"Tolerability and hepatotoxicity of antifungal use in empirical and definitive therapy for invasive fungal infection: a systematic review and meta-analysis","author":"Wang","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbmt.2010.05.002_bib22","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1128\/AAC.01337-06","article-title":"Once-weekly micafungin therapy is as effective as daily therapy for disseminated candidiasis in mice with persistent neutropenia","volume":"51","author":"Gumbo","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbmt.2010.05.002_bib23","unstructured":"Buell D, Kovada L, Drake T, Fisco C. Alternative day dosing of micafungin in the treatment of esophageal candidiasis. 47th Annual conference of American Society of Hematology 2005: abstr. 719."},{"key":"10.1016\/j.bbmt.2010.05.002_bib24","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1128\/AAC.46.12.3846-3853.2002","article-title":"In vitro activity of micafungin (FK-463) against Candida spp.: microdilution, time-kill, and postantifungal-effect studies","volume":"46","author":"Ernst","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbmt.2010.05.002_bib25","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1128\/AAC.47.10.3149-3154.2003","article-title":"Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States","volume":"47","author":"Ostrosky-Zeichner","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbmt.2010.05.002_bib26","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/JCM.00566-08","article-title":"Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bbmt.2010.05.002_bib27","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/AAC.47.8.2640-2643.2003","article-title":"Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp","volume":"47","author":"Arikan","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbmt.2010.05.002_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/13693780802262123","article-title":"Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan","volume":"47","author":"Ikeda","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.bbmt.2010.05.002_bib29","unstructured":"Mouton JW GE, Curfs-Breuker I, Klaassen CH, Meis JF. Susceptibility of micafungin in Candida strains isolated from patients with invasive Candida infections by EUCAST methodology. 4th Trends in Medical Mycology, Athens, Greece, 2009."}],"updated-by":[{"DOI":"10.1016\/j.bbmt.2011.01.009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000}}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110002004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110002004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T07:22:18Z","timestamp":1544426538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879110002004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1083879110002004"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.05.002","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}